Preclinical studies propose that retatrutide might affect weight problems-connected most cancers progression. In a examine led by Marathe et al., retatrutide-induced weight-loss decreased tumor engraftment, delayed tumor onset, and appreciably attenuated tumor expansion in pancreatic and lung most c